Ukuzaji na utumiaji wa pete za kioksidishaji zilizochaguliwa na vikundi vingi vya sulfhydryl

Ukuzaji na utumiaji wa pete za kioksidishaji zilizochaguliwa na vikundi vingi vya sulfhydryl

Research background and challenges

Selective ring closure of multiple sulfhydryl compounds is a key step in the synthesis of sulfur-containing heterocyclic compounds, but the traditional method has the following problems:

  • Multiple sulfhydryl reaction activities are similar, making it difficult to achieve selective control. Many side reactions, complex products, and difficult to isolate and purify. The reaction conditions are harsh and the scope of application is limited. We have successfully developed a new selective oxidative ring-closing technology, which completely solves the above problems and achieves efficient and precise ring-closing reaction.

Technical breakthroughs

  • Innovative oxidation system: The first alkyne amide-based oxidation system is proposed, which significantly improves the selectivity.
  • Unique reaction design: through a variety of different positions of the sulfhydryl substrate, the precise ring closure of multiple sulfhydryl substrates is achieved.

Technical Advantages

  • High selectivity: precise identification of target sites among multiple sulfhydryl substrates to achieve single product generation.
  • High efficiency: the reaction conditions are mild, and the reaction yield is significantly improved.
  • Universality: applicable to the synthesis of various sulfur-containing heterocyclic compounds.

Application Fields

  • Drug synthesis: construction of sulfur-containing heterocyclic drug molecules (k.m., thiophene, benzothiophene, dithiopyrrolidine, nk.).
  • Functional materials: preparation of sulfur-containing polymer materials (e.g. self-repairing materials, conductive polymers, nk.).
  • Chemical biology: study the formation and function of protein disulfide bonds.

Admin Avatar

Xiaoxia Chen

Dawa Mpya R&D Fundi Utaalamu wa Msingi: Ugunduzi unaolengwa, uhusiano wa shughuli za muundo (SAR) uchambuzi, viunganishi vya peptide-dawa (PDCs), na maendeleo ya peptidi za kupambana na kuzeeka na kimetaboliki.

Wasifu: Xiaoxia Chen ameongoza ugunduzi wa mapema na utafiti wa mapema wa dawa kadhaa za kimetaboliki na peptidi zinazolengwa na tumor.. Yeye sio tu mahiri katika uchunguzi wa hali ya juu wa maktaba za peptidi lakini pia ana ustadi wa kutumia baiolojia ya hesabu inayosaidiwa na AI kwa muundo wa mfuatano wa peptidi ya de novo.. Kwa sasa, anaongoza timu inayojitolea kwa utafiti wa kina na ukuzaji wa wahusika wengi wa kizazi kijacho. (kama vile mbili- au peptidi za kupunguza mafuta zinazolengwa mara tatu) na peptidi za kutengeneza tishu zenye kazi sana.

Ukweli Umeangaliwa & Miongozo ya Uhariri
Imekaguliwa na: Wataalam wa Mambo ya Mada
Shiriki makala hii
Nyumbani Tafuta Whatsapp Huduma Bidhaa